Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis of malignant hyperphenylalaninaemia.

Literature DB >> 475407

Diagnosis of malignant hyperphenylalaninaemia.

D M Danks, R G Cotton, P Schlesinger.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1979 PMID： 475407 PMCID： PMC1545571 DOI： 10.1136/adc.54.5.329

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

× No keyword cloud information.

9 in total

1. Malignant hyperphenylalaninaemia--current status (June 1977).

Authors: D M Danks; K Bartholomé; B E Clayton; H Curtius; H Gröbe; S Kaufman; R Leeming; W Pfleiderer; H Rembold; F Rey
Journal: J Inherit Metab Dis Date: 1978 Impact factor: 4.982

2. Pteridines and phenylketonuria: report of a workshop: Introductory comments.

Authors: D M Danks
Journal: J Inherit Metab Dis Date: 1978 Impact factor: 4.982

3. Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors: S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal: N Engl J Med Date: 1975-10-16 Impact factor: 91.245

4. A disorder of biogenic amines in dihydropteridine reductase deficiency.

Authors: I J Butler; S H Koslow; A Krumholz; N A Holtzman; S Kaufman
Journal: Ann Neurol Date: 1978-03 Impact factor: 10.422

5. Letter: Variant forms of phenylketonuria.

Authors: D M Danks; R G Cotton; P Schlesinger
Journal: Lancet Date: 1976-06-05 Impact factor: 79.321

6. Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.

Authors: K Bartholomé; D J Byrd
Journal: Lancet Date: 1975-11-22 Impact factor: 79.321

7. Urinary dihydroxanthopterin in the diagnosis of malignant hyperphenylalaninemia and phenylketonuria.

Authors: P Schlesinger; B M Watson; R G Cotton; D M Danks
Journal: Clin Chim Acta Date: 1979-03-01 Impact factor: 3.786

8. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.

Authors: I Smith; B E Clayton; O H Wolff
Journal: Lancet Date: 1975-05-17 Impact factor: 79.321

9. Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis.

Authors: J Schaub; S Däumling; H C Curtius; A Niederwieser; K Bartholomé; M Viscontini; B Schircks; J H Bieri
Journal: Arch Dis Child Date: 1978-08 Impact factor: 3.791